Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Latex Hypersensitivity D020315 1 associated lipids
Stroke D020521 32 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Nakano T et al. Effects of platelet depletion on PMA-induced acute lung injury in awake sheep. 1995 Respir Physiol pmid:8570923
Sorem KA and Siler-Khodr TM Placental prostanoid release in severe intrauterine growth retardation. 1995 Placenta pmid:8570572
Kobayashi I et al. Saiboku-To, a herbal extract mixture, selectively inhibits 5-lipoxygenase activity in leukotriene synthesis in rat basophilic leukemia-1 cells. 1995 J Ethnopharmacol pmid:8569245
Altavilla D et al. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis. 1995 Eur. J. Pharmacol. pmid:8566149
Glaser K et al. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. 1995 Eur. J. Pharmacol. pmid:8566109
Kawikova I et al. Bradykinin-induced release of thromboxane B2 into bronchoalveolar lavage fluid of guinea pigs: relationship to airflow obstruction. 1995 Eur. J. Pharmacol. pmid:8566097
Satterwhite JH and Boudinot FD Effects of age on the pharmacodynamics of naproxen in the rat. 1995 Sep-Oct Exp. Gerontol. pmid:8557098
Liu W et al. [Effects of selenium and vitamin E on arachidonic acid metabolism in experimental myocardial ischaemia]. 1995 Zhonghua Yu Fang Yi Xue Za Zhi pmid:8556938
Wang TL et al. The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: the role of antiplatelet therapy. 1995 Pacing Clin Electrophysiol pmid:8552510
Morioka K et al. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass. 1996 J. Thorac. Cardiovasc. Surg. pmid:8551788
Kato A et al. Role of thromboxane A2 and prostacyclin in uninephrectomy-induced attenuation of ischemic renal injury. 1995 Kidney Int. pmid:8544417
Daugschies A Oesophagostomum dentatum: population dynamics and synthesis of prostanoids by histotropic stages cultured in vitro. 1995 Exp. Parasitol. pmid:8542999
Lees P et al. Pharmacodynamics and pharmacokinetics of carprofen in the horse. 1994 Equine Vet. J. pmid:8542839
Blache D et al. Occurrence and biological effects of cholesteryl sulfate on blood platelets. 1995 Biochim. Biophys. Acta pmid:8541337
Shimizu Y et al. Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation. 1995 Transplant. Proc. pmid:8539906
Landoni MF and Lees P Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling. 1995 Equine Vet. J. pmid:8536660
Smith AJ et al. Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A2 and prostacyclin in plasma. 1995 Br J Obstet Gynaecol pmid:8534627
Narita S et al. [Studies on thromboxane B2 level in nasal lavage fluid after antigen challenge in patients with allergic rhinitis and guinea pig models]. 1995 Arerugi pmid:8534212
Vezza R et al. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. 1995 J. Pharmacol. Exp. Ther. pmid:8531121
Itoh K et al. Relationship between airway eosinophilia and airway hyperresponsiveness in a late asthmatic model of guinea pigs. 1996 Int. Arch. Allergy Immunol. pmid:8527956
Nosál R et al. The H1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation, malondialdehyde formation and thromboxane production in vitro. 1995 Inflamm. Res. pmid:8520978
Eisenmann CJ and Miller RK Cadmium and glutathione: effect on human placental thromboxane and prostacyclin production. 1995 Jan-Feb Reprod. Toxicol. pmid:8520130
Rabinovici R et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. 1993 J. Appl. Physiol. pmid:8514698
Renz H et al. Tumor necrosis factor-alpha, interleukin 1, eicosanoid, and hydrogen peroxide release from macrophages exposed to glove starch particles. 1993 Clin. Immunol. Immunopathol. pmid:8513589
Dunn CW and Horton JW Role of angiotensin II in neonatal sepsis. 1993 Circ. Shock pmid:8508519
Fletcher JR et al. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. 1993 Ann. Surg. pmid:8507112
Fisher M Increased thromboxane biosynthesis in patients with acute cerebral ischemia. 1993 Stroke pmid:8506568
Budd JS et al. The effectiveness of low dose slow release aspirin as an antiplatelet agent. 1993 J R Soc Med pmid:8505747
Penning LC et al. Ca(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro. 1993 Biochem. J. pmid:8503851
Ferretti A et al. Ingestion of marine oil reduces excretion of 11-dehydrothromboxane B2, an index of intravascular production of thromboxane A2. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8497491
Ciabattoni G et al. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung. 1993 Br. J. Pharmacol. pmid:8495242
Schneidkraut MJ and Carlson RW Cecal ligation and puncture is associated with pulmonary injury in the rat: role of cyclooxygenase pathway products. 1993 Prostaglandins pmid:8493358
Mustad VA et al. Comparison of the effects of diets rich in stearic acid versus myristic acid and lauric acid on platelet fatty acids and excretion of thromboxane A2 and PGI2 metabolites in healthy young men. 1993 Metab. Clin. Exp. pmid:8487669
Zwischenberger JB et al. Pathophysiology of ovine smoke inhalation injury treated with extracorporeal membrane oxygenation. 1993 Chest pmid:8486048
Yamanaka S et al. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. 1993 Prostaglandins pmid:8484010
Alanko J Effects of phenols on eicosanoid synthesis in A23187-stimulated human whole blood. 1993 Prostaglandins pmid:8484008
Yasu T et al. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. 1993 Am. J. Cardiol. pmid:8480641
Böck M et al. Storage of single-donor platelet concentrates: metabolic and functional changes. 1993 Transfusion pmid:8480351
Smith CC et al. The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man. 1993 Clin. Auton. Res. pmid:8477181
Mohri H and Ohkubo T Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men. 1993 Ann Pharmacother pmid:8477113
Hauth JC et al. Low-dose aspirin therapy to prevent preeclampsia. 1993 Am. J. Obstet. Gynecol. pmid:8475955
Arruzazabala ML et al. Effects of Policosanol on platelet aggregation in rats. 1993 Thromb. Res. pmid:8475481
Ciabattoni G et al. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. 1993 J. Am. Coll. Cardiol. pmid:8473644
Kroegel C and Matthys H Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. 1993 Immunology pmid:8473016
Sagripanti A et al. [The use of picotamide in nephropathy with mesangial IgA deposits. The effect on thromboxane generation]. 1993 Clin Ter pmid:8472511
Elmadfa I et al. Influence of a single parenteral application of a 10% fish oil emulsion on plasma fatty acid pattern and the function of thrombocytes in young adult men. 1993 Ann. Nutr. Metab. pmid:8470873
García-Valdecasas JC et al. Prostaglandin metabolism and hemodynamic alterations during human liver transplantation. 1993 Transplant. Proc. pmid:8470202
Lueddeckens G et al. Importance of secondary TXA2 release in mediating of endothelin-1 induced bronchoconstriction and vasopressin in the guinea-pig. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8469685
Byrne JG et al. Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury? 1993 J. Thorac. Cardiovasc. Surg. pmid:8469003
Grieve EM et al. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition. 1993 Biochem. Pharmacol. pmid:8466554